Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) price on Thursday, May 01, rose 0.59% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.14.
A look at the stock’s price movement, the close in the last trading session was $5.11, moving within a range at $5.026 and $5.55. The beta value (5-Year monthly) was -0.528. Turning to its 52-week performance, $7.27 and $1.58 were the 52-week high and 52-week low respectively. Overall, AMLX moved 53.89% over the past month.
Amylyx Pharmaceuticals Inc’s market cap currently stands at around $457.89 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-03.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AMLX is a 100% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend AMLX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AMLX’s current price about 21.10% and 34.79% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 68.23, while 7-day volatility ratio is 7.81% and 9.33% in the 30-day chart. Further, Amylyx Pharmaceuticals Inc (AMLX) has a beta value of -0.59, and an average true range (ATR) of 0.35. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $11 and high of $11. Looking at the price targets, the low is -114.01% off current price level while to achieve the yearly target high, price needs to move -114.01%. Nonetheless, investors will most likely welcome a -114.01% jump to $11 which is the analysts’ median price.
If we refocus on Amylyx Pharmaceuticals Inc (NASDAQ:AMLX), historical trading data shows that trading volumes averaged 0.94 over the past 10 days and 807.19K over the past 3 months. The company’s latest data on shares outstanding shows there are 68.63 million shares.
The 25.22% of Amylyx Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 56.23% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.31 million on 2025-04-15, giving us a short ratio of 5.68. The data shows that as of 2025-04-15 short interest in Amylyx Pharmaceuticals Inc (AMLX) stood at 534.0000200000001 of shares outstanding, with shares short rising to 3.75 million registered in 2025-03-14. Current price change has pushed the stock 35.98% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AMLX stock continues to rise going into the next quarter.
